Acute Management of Diabetic Ketoacidosis with Hyperkalemia and Hypernatremia
This patient presents with diabetic ketoacidosis (DKA) requiring immediate fluid resuscitation, insulin therapy, and aggressive electrolyte management—bicarbonate is NOT indicated at this pH level.
Immediate Diagnostic Confirmation
- Calculate the anion gap: Na⁺ – (HCO₃⁻ + Cl⁻) to confirm high anion-gap metabolic acidosis; the elevated glucose (289 mg/dL), low bicarbonate (16.4 mmol/L), and elevated lactate (3.31 mmol/L) strongly suggest DKA. 1
- Obtain serum/urine ketones (beta-hydroxybutyrate preferred) to definitively confirm DKA, as the combination of hyperglycemia >250 mg/dL, bicarbonate <18 mmol/L, and positive ketones defines the diagnosis. 1
- Measure arterial blood gas to determine pH and PaCO₂; the compensatory respiratory alkalosis (PaCO₂ 29.5 mmHg) indicates the patient is hyperventilating appropriately to offset the metabolic acidosis. 1, 2
Critical Initial Management Priorities
Fluid Resuscitation (First Priority)
- Administer isotonic saline (0.9% NaCl) at 15–20 mL/kg/h during the first hour to restore intravascular volume and renal perfusion; this addresses the hypernatremia (152.7 mmol/L) and prerenal component. 1, 3
- After the initial bolus, switch to 0.45% NaCl at 4–14 mL/kg/h because the corrected sodium is elevated (hypernatremia), and hypotonic saline will help normalize sodium while continuing volume expansion. 1
- Monitor serum sodium, potassium, and glucose every 2–4 hours during active resuscitation to guide fluid choice and prevent rapid osmotic shifts. 1, 3
Hyperkalemia Management (Concurrent Priority)
- Do NOT start insulin until serum potassium is confirmed >3.3 mEq/L; however, this patient's potassium is 6.41 mEq/L, so insulin can be initiated immediately. 1, 3
- Recognize that the hyperkalemia is pseudohyperkalemia from extracellular shift due to insulin deficiency and acidosis; insulin therapy and volume expansion will drive potassium intracellularly and the serum level will drop rapidly. 1, 3
- Obtain an ECG immediately to assess for life-threatening cardiotoxicity from hyperkalemia (peaked T-waves, QRS widening); if present, consider temporizing measures (calcium gluconate, insulin/glucose) while definitive DKA therapy proceeds. 3
- Anticipate hypokalemia within 2–4 hours of starting insulin; once potassium falls below 5.3 mEq/L, add 20–30 mEq/L potassium (2/3 KCl and 1/3 KPO₄) to IV fluids. 1, 3
Insulin Therapy (After Confirming K⁺ >3.3 mEq/L)
- Start continuous IV regular insulin at 0.1 units/kg/h after confirming serum potassium >3.3 mEq/L; this is the cornerstone of DKA therapy and will correct the ketoacidosis, lower glucose, and shift potassium intracellularly. 1, 3
- When plasma glucose reaches approximately 250 mg/dL, reduce insulin to 0.05–0.1 units/kg/h and add 5–10% dextrose to IV fluids to prevent hypoglycemia while continuing to clear ketones. 1
- Do NOT stop insulin until DKA resolves (glucose <200 mg/dL, bicarbonate ≥18 mEq/L, venous pH ≥7.3), even if glucose normalizes first. 1
Bicarbonate Therapy Decision
Bicarbonate is NOT indicated in this patient. 1, 3, 4
- The bicarbonate level of 16.4 mmol/L and compensatory PaCO₂ of 29.5 mmHg indicate the pH is likely ≥7.0; bicarbonate therapy is only indicated in DKA when arterial/venous pH falls below 6.9–7.0. 1, 3
- Obtain an arterial or venous blood gas to confirm pH; if pH is ≥7.0, do not give bicarbonate—insulin and fluid resuscitation alone will correct the acidosis. 1, 3
- If pH is documented <6.9, administer 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/h; if pH is 6.9–7.0, give 50 mmol in 200 mL at 200 mL/h. 1, 3
- Bicarbonate therapy in DKA can worsen hypokalemia, cause paradoxical intracellular acidosis, and delay ketone clearance; it should be reserved only for life-threatening acidemia. 1, 3
Monitoring and Resolution Targets
- Check venous pH and anion gap every 2–4 hours to assess DKA resolution; repeat arterial blood gases are generally unnecessary after the diagnosis is established. 1
- Monitor serum potassium every 2–4 hours because insulin and alkalinization drive potassium intracellularly, creating a risk of life-threatening hypokalemia. 1, 3
- DKA is considered resolved when: glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, and venous pH ≥7.3. 1
- Track serum sodium closely; as glucose falls, sodium will rise (corrected sodium = measured Na + 1.6 × [(glucose – 100)/100]), and hypernatremia may worsen transiently before improving with hypotonic fluids. 1
Management of Elevated Lactate
- The lactate of 3.31 mmol/L likely reflects tissue hypoperfusion from volume depletion; aggressive fluid resuscitation should normalize lactate as perfusion improves. 2
- Lactate >4 mmol/L is associated with significant mortality; this patient's level is elevated but not critically high, and should improve with volume expansion. 2
- Do NOT give bicarbonate for lactic acidosis when pH ≥7.15; two randomized controlled trials showed no hemodynamic benefit and potential harm (sodium overload, increased lactate, higher PaCO₂, reduced ionized calcium). 1, 3
Common Pitfalls to Avoid
- Do not administer bicarbonate empirically without measuring pH; routine bicarbonate is contraindicated in DKA with pH ≥7.0 and can cause rebound alkalosis, hypokalemia, and paradoxical CNS acidosis. 1, 3
- Do not start insulin before confirming potassium >3.3 mEq/L (not applicable here, but critical in hypokalemic patients); insulin without adequate potassium can precipitate fatal arrhythmias. 1
- Do not use 0.9% saline throughout resuscitation in hypernatremic patients; switch to 0.45% NaCl after the initial bolus to avoid worsening hypernatremia. 1
- Do not ignore the compensatory respiratory alkalosis; the low PaCO₂ (29.5 mmHg) is appropriate compensation for metabolic acidosis, and attempting to "correct" it by reducing ventilation would be harmful. 2
- Do not delay potassium supplementation; once K⁺ drops below 5.3 mEq/L, add potassium to IV fluids immediately to prevent life-threatening hypokalemia as insulin drives potassium intracellularly. 1, 3